TENX tenaxthera.com: שווי הפעילות העסקית

Tenax Therapeutics (TENX) aims to expand its presence in the cardiac market through the introduction of a pulmonary hypertension drug. The effectiveness of this strategy relies on strict adherence to molecule transportation conditions to research centers. This daily price chart on the GURU.Markets platform shows an Enterprise Value of -47.62. Further growth is based on the outcomes of final-stage trials and regulatory verdicts, regardless of the broader economy.

Tenax Therapeutics (TENX) focuses on developing highly specialized cardiology treatments to combat pulmonary hypertension. The calculation of this metric combines market capitalization with liabilities, subtracting available cash. This formula determines the actual cost of a full business buyout, accounting for its net debt. The investor utilizes this metric to assess the asset's fundamental stability in the face of competition from pharmaceutical behemoths. The price action of the business's market value, adjusted for net debt, reflects the company's real price.